Researchers present three studies highlighting advances in clinical cardiology, including a new drug-exercise combination that improves image quality and reduces side effects. The studies also explore the best medical and interventional treatment for patients with acute coronary syndromes.
A recent study found that combining a platelet inhibitor with an embolic protection device improves renal function in patients undergoing renal artery stenting. The use of abciximab reduced the occurrence of platelet-rich thrombi, while Angioguard alone was not associated with improved outcomes.
Researchers studied the effectiveness of estradiol and rapamycin-eluting stents in reducing in-stent restenosis. However, they found no significant difference between the two groups, indicating that adding estradiol to rapamycin-coated stents may not provide a measurable benefit.
The EXACT study found that community hospital physicians can provide exemplary outcomes for patients in need of carotid stenting with appropriate experience levels and device training. The use of embolic protection devices has been shown to reduce peri-procedural complications by 4.5% compared to the SECuRITY study.
Long-term safety of drug-eluting stents in off-label use shows low mortality rates, with cardiac mortality at 0.8%, but high risk of late stent thrombosis among non-responders to clopidogrel. The MATRIX Registry found that 34% of patients had diabetes and 33% a history of heart attack.
A randomized controlled trial found that peri-procedural hydration treatment with sodium bicarbonate and sodium chloride show similar rates of protection against contrast-induced nephropathy. The study evaluated 353 patients undergoing cardiac procedures and found no significant differences in kidney function between the two groups.
A combination of aliskiren and valsartan showed improved blood pressure control compared to individual treatments or placebo. The dual renin system blocking drug combo reduced systolic and diastolic blood pressure, achieving a goal blood pressure of 140/90 mmHg in 49.3% of patients.
A Phase 1 study evaluating a novel protein kinase C inhibitor, KAI-9803, suggests potential benefit in healing time and tissue function for heart attack patients. The trial showed improved tissue perfusion and reduced infarct size at lower dose levels.
Studies found that ramipril and rosiglitazone slow atherosclerosis progression, while rosuvastatin treatment reduces arterial plaque buildup in low-risk individuals. Additionally, high-dose atorvastatin improves outcomes in patients with acute coronary syndromes undergoing percutaneous coronary intervention
The EVEREST trial shows that oral tolvaptan improves patient-assessed global clinical status, body weight, and reduces dyspnea in hospitalized heart failure patients, while also measuring long-term effects on mortality and hospitalization rates.
A Phase 1 trial of mesenchymal stem cells (MSCs) has shown significant improvements in heart function and reduced side effects in patients with acute myocardial infarction (MI). The study, led by Joshua Hare, M.D., found that MSC-treated patients had lower rates of cardiac arrhythmias and improved heart, lung, and global function.
Researchers tested a new cholesterol treatment LY518674 (LY5) in two studies, but found it showed no benefits compared to fenofibrate. Both drugs raised safety concerns, particularly for kidney function.
Researchers studied the outcomes of treating ST- elevation myocardial infarction with PCI alone or with distal protection, finding similar major adverse cardiac events and electrocardiographic results. However, post-procedure blood flow was improved in patients treated with distal protection.
Researchers present new catheter-based approaches to repairing the mitral valve and treating coronary plaque, showing improved safety and feasibility. The MONARC system and sideKick stenting system demonstrate significant benefits in patients with moderate-to-severe mitral regurgitation and bifurcation lesions.
Researchers found that lowering blood pressure with valsartan and other approaches improved diastolic function in patients with hypertension. The study, known as VALIDD, showed significant improvements in diastolic dysfunction, regardless of whether RAAS was inhibited or not.
New implantable device stimulates body's regulatory systems to control high blood pressure; computerized angioplasty protocol reduces risk of renarrowing and complications after coronary stenting.
A new noninvasive test may identify patients with stage II and III nonischemic cardiomyopathy who are likely to benefit from an ICD. The test, called abnormal T-Wave Alternans (TWA), shows that patients with a normal test have a very good prognosis and are unlikely to benefit from the device.
A new study found that serial outpatient administration of nesiritide did not significantly improve outcomes in patients with advanced heart failure. The trial, FUSION II, tested the safety and efficacy of this treatment approach and showed no evidence of renal harm or excess mortality.
A community-based study found that intensive dietary therapy and early dosing with a medication blocking harmful hormonal effects in the heart can improve cardiovascular health and survival rates after a heart attack. The Mediterranean diet was equally beneficial as a low-fat, low-cholesterol diet.
A new study presents the first US controlled clinical trial using muscle stem cells to treat congestive heart failure. The procedure involves injecting autologous skeletal myoblasts into scarred tissue via a minimally invasive catheter, showing improved quality of life and potential cardiac function.
Researchers evaluated the safety and performance of a new bioabsorbable stent that eliminates several problems associated with metallic stents. At 30 days, device success was extremely high, and no patients experienced major adverse cardiac events or stent thrombosis.
Researchers investigate lifestyle choices and their impact on heart risks, exploring the effects of dark chocolate and nicotine patches on cardiovascular health. Studies find that flavonoids in dark chocolate can improve endothelial function in adults with BMI between 25-35 kg/m2.
A new study attributes long-term survival rates after cardiac surgery to the rising use of cardiac drugs, including low-dose aspirin. Researchers found that lower doses of therapies may be just as beneficial while lowering side effects.
Researchers examined long-term follow-up of stents placed in infants with congenital heart disease, finding sustained benefits and the ability to safely enlarge stents as children grow. Additionally, studies investigated percutaneous pulmonary valve implantation, analyzing its mid-term outcomes and impact on device removal.
A novel platelet therapy, SCH 530348, has demonstrated safety and efficacy in reducing percutaneous coronary intervention (PCI) complications. Major adverse events were reduced by 1.6-3.5% in low-dose cohorts compared to placebo. The treatment also showed a lower risk of death or major adverse events and heart attack compared to placebo.
A study comparing drug-eluting stents (DES) and bare-metal stents (BMS) found similar rates of complications, including stent thrombosis, MI, and mortality. However, DES patients had a slightly increased risk of stent thrombosis and heart attack between 12-15 months after implantation.
The SPIRIT-III trial shows that the Xience V Everolimus Eluting Coronary Stent System reduces target vessel failure, ischemic-driven revascularization procedures, and major adverse cardiac events compared to paclitaxel-eluting stents. This suggests a potential enhancement of outcomes for patients with coronary artery disease.
A new multislice CT scan can quickly detect fatty blockages in the heart's arteries, ruling out heart attacks and reducing diagnostic time. This simple outpatient scan allows doctors to confidently send home patients with normal coronary arteries, while accurately identifying those with serious heart disease.
A recent meta-analysis supports the existence of metabolic syndrome as a predictor of cardiovascular disease and death, particularly in women. The study analyzed over 37 studies and found that the constellation of conditions constituting metabolic syndrome increases heart risk compared to individual factors alone.
A study examines the relationship between plaque build-up and artery blockage in patients with moderate risk of coronary artery disease. The results show that MSCT detects atherosclerosis, while MPI identifies ischemia, suggesting that narrowing of coronary arteries may not harm blood flow to the heart.
Research reveals that heart attack-related depression significantly increases the risk of further cardiovascular emergencies. The DepreMI Study found that incident post-heart attack depression is linked to a poor prognosis, warranting more targeted screenings and treatments.
Whole-heart MRI technology has advanced to detect heart disease more effectively, reducing motion blurring and improving image quality. The study found that the technique was accurate in detecting significant narrowing of coronary arteries in 87% of patients.
Research shows that regular exercise can help obese children shrink their waistlines and reduce their risk of developing cardiovascular disease. After six months, exercising regularly resulted in improved artery flexibility, reduced BMI, and lower cholesterol levels.
New research shows that consuming walnuts with high-fat meals limits artery damage and preserves elasticity. Unlike olive oil, walnuts' nutrient arginine helps maintain nitric oxide production, keeping arteries flexible.
Preliminary research suggests that famotidine, a heartburn medication, can help decrease the effects of chronic heart failure by blocking a chemical reaction that damages diseased hearts. However, more testing is required to verify the results, including dosage and safety issues.
Researchers found that elevated troponin-T and N-terminal pro-B-type natriuretic peptide levels in the blood indicate high risk of deadly heart attacks. Patients with low levels may not benefit from aggressive treatment and could be harmed by invasive procedures.
Researchers found that patient outcomes improved when treatment was based on the doctor's recommendation, with a significantly lower incidence of problems compared to alternative treatments. The study's results highlight the importance of physician judgment in making therapeutic decisions for patients with severe coronary artery disease.
The new ACC/AHA/ESC Guidelines outline recommendations for the evaluation and treatment of patients with ventricular arrhythmias and sudden cardiac death, addressing inconsistencies in previous guidelines. The guidelines provide individualized management based on symptom burden and severity of underlying heart disease.
Eating a single high-fat meal can reduce the body's ability to protect itself against heart disease and stroke by impairing the 'good' cholesterol's protective qualities. In contrast, consuming polyunsaturated fat-rich meals can increase the anti-inflammatory properties of HDL, helping to prevent plaque buildup.
The American College of Cardiology has released new appropriateness criteria for cardiac computed tomography (CCT) and cardiac magnetic resonance imaging (CMR). These guidelines aim to help clinicians, patients, and payers determine when these advanced imaging tests are necessary. The criteria assess the risks and benefits of each test...
A study found that offspring of type 2 diabetic parents exhibit endothelial dysfunction and increased risk of atherosclerosis, even without diabetes. The research suggests that early treatment may prevent progression of the disease, highlighting the importance of identifying high-risk groups.
Researchers detected subtle changes in left ventricle walls using MRI tagging, showing an association between atherosclerosis and reduced heart pumping function. The study found early signs of atherosclerosis in carotid arteries related to fine changes in heart contraction.
The new guidelines provide practical recommendations for evaluating patients with heart murmurs, preventing endocarditis, and treating concomitant coronary artery disease. The guidelines include more precise definitions of mild, moderate, and severe valvular disease, which may prompt earlier referrals for surgery.
A study found that obese teenagers have larger and heavier hearts, with impaired function, which cannot be explained by high blood pressure alone. The research suggests that childhood obesity can lead to long-term consequences on heart disease risk.
A study by Yale University School of Medicine found that door-to-balloon time matters for all patients, regardless of time to presentation. The results show a significant decrease in mortality rates when patients receive rapid treatment, even if they arrive late.
A study found that training on a virtual 'patient' improved carotid angiography skills in cardiologists, with reduced catheter errors and faster procedure times. The use of simulators provides an objective measure of performance, allowing for the tracking of individual trainees' progress and evaluation of their competence.
Researchers found that aerobic training can reverse abnormal production of certain neurohormones that cause severe symptoms of heart failure. The study suggests that exercise may be a novel non-pharmacological aid for improving functional capacity, systolic function, and quality of life in heart failure patients.
A study has found that taller people are more likely to develop atrial fibrillation, with the risk increasing by 32% for those in the tallest quartile compared to the shortest. The researchers suggest that tall individuals may need more aggressive risk factor attenuation strategies.
Researchers found that placental growth factor levels are higher in heart attack patients and correlate with cardiac function improvement. The study suggests PlGF promotes tissue repair after a heart attack by mobilizing stem cells.
A study found that nearly half of elderly Beijing residents have metabolic syndrome, a cluster of five risk factors for cardiovascular disease. The prevalence of metabolic syndrome in China is on par with Western populations, posing a significant burden on the healthcare system.